Richard Bernstein, MD, PhD – FDA 483, Oct 10, 2019
An FDA inspection of Richard Bernstein, MD, PhD, a clinical investigator in Chicago, IL, revealed significant deficiencies across two studies, RESPECT-ESUS and SOCRATES. Observations included widespread protocol deviations such as missing diagnostic evaluations, failure to re-image brains, incomplete screening procedures, and delayed reporting of adverse events. Additionally, the firm failed to obtain proper informed consent for sub-studies and did not implement revised consent forms, alongside maintaining inadequate and inaccurate case histories, including lost study records.
ID · 63ca6cb8-2b4d-4bbd-8b2e-8f333c2d0fc5
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.